Skip to content

AARD AARD Return on invested capital

Return on invested capital at other companies

AbbVie logo
AbbVieABBV
17.1%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-49.2%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-197.9%-87.7pp
Viking Therapeutics logo
Viking TherapeuticsVKTX
-59.2%-292pp
Arvinas logo
ArvinasARVN
-56.5%-101pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-27.6%-33.2pp

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

Based on trailing twelve months.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's return on invested capital?
AARD (AARD) reported return on invested capital of -99.8% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.